Published 6 issues per year
ISSN Print: 1040-8401
ISSN Online: 2162-6472
IF:
1.3
5-Year IF:
2.6
Eigenfactor:
0.00079
JCI:
0.24
SJR:
0.429
SNIP:
0.287
CiteScore™::
2.7
H-Index:
81
Indexed in
Infectious Tolerance as Candidate Therapy for Type 1 Diabetes: Transfer of Immunoregulatory Properties from Human Regulatory T Cells to Other T Cells and Proinflammatory Dendritic Cells
Get access
ABSTRACT
Type 1 diabetes is a T-cell−mediated autoimmune disease in which the insulin-producing cells in the islets of Langerhans are selectively destroyed. Although symptomatic insulin therapy is able to control glucose levels in the blood, many patients do not obtain the desired glycemic control, which increases the risk of diabetic complications. While many immunotherapeutic efforts to intervene in the disease process focus on systemic immune-suppressive therapies, antigen-specific immune modulation represents an attractive alternative. Dendritic cells modulated with 1.25(OH)2 vitamin D3, and dexamethasone (tolerogenic DCs) loaded with islet antigens induce Ag-specific regulatory CD4 T cells (iaTregs), offering a tissue-specific intervention therapy. iaTregs exert their function via linked suppression to diminish effector cells by modulating pro-inflammatory DCs to upregulate inhibitory receptors. In turn, these re-educated mature DCs induce IL-10−producing cells from the naive T-cell pool. Thus, tolerogenic DCs transfer regulatory properties to pro-inflammatory DCs via iaTregs (i.e., infectious tolerance). In this review, we describe the current knowledge regarding regulatory mechanisms of these tolerogenic DCs and the Tregs that they induce, and we propose that cell therapy with human tolerogenic DCs provides new opportunities for immune intervention in patients with autoimmune diseases.
-
Perez Shira, Fishman Sigal, Bordowitz Amos, Margalit Alon, Wong F. Susan, Gross Gideon, Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells, Immunology, 143, 4, 2014. Crossref
-
Roep Bart O., Tree Timothy I. M., Immune modulation in humans: implications for type 1 diabetes mellitus, Nature Reviews Endocrinology, 10, 4, 2014. Crossref
-
Zhao Gaoping, Moore Daniel J., Kim James I., Lee Kang Mi, O'Connor Matthew, Yang Maozhu, Marshall Andrew F., Lei Ji, Schuetz Christian, Markmann James F., Deng Shaoping, An immunosufficient murine model for the study of human islets, Xenotransplantation, 21, 6, 2014. Crossref
-
Dastagir Shamael R., Postigo-Fernandez Jorge, Xu Chunliang, Stoeckle James H., Firdessa-Fite Rebuma, Creusot Rémi J., Efficient Presentation of Multiple Endogenous Epitopes to Both CD4 + and CD8 + Diabetogenic T Cells for Tolerance, Molecular Therapy - Methods & Clinical Development, 4, 2017. Crossref
-
Baekkeskov Steinunn, Hubbell Jeffrey A., Phelps Edward A., Bioengineering strategies for inducing tolerance in autoimmune diabetes, Advanced Drug Delivery Reviews, 114, 2017. Crossref
-
Bidmon Nicole, Kind Sonja, Welters Marij J.P., Joseph-Pietras Deborah, Laske Karoline, Maurer Dominik, Hadrup Sine Reker, Schreibelt Gerty, Rae Richard, Sahin Ugur, Gouttefangeas Cécile, Britten Cedrik M., van der Burg Sjoerd H., Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance, Journal of Immunological Methods, 458, 2018. Crossref
-
Diamond Don Jeffrey, La Rosa Corinna, Chiuppesi Flavia, Contreras Heidi, Dadwal Sanjeet, Wussow Felix, Bautista Supriya, Nakamura Ryotaro, Zaia John A., A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection, Expert Review of Vaccines, 17, 10, 2018. Crossref
-
Wang Ping, Moore Anna, In Vivo Magnetic Resonance Imaging of Small Interfering RNA Nanodelivery to Pancreatic Islets, in RNA Imaging, 1372, 2016. Crossref
-
Suwandi Jessica S., Laban Sandra, Vass Kincsὅ, Joosten Antoinette, van Unen Vincent, Lelieveldt Boudewijn P.F., Höllt Thomas, Zwaginga Jaap Jan, Nikolic Tatjana, Roep Bart O., Multidimensional analyses of proinsulin peptide-specific regulatory T cells induced by tolerogenic dendritic cells, Journal of Autoimmunity, 107, 2020. Crossref
-
Brusko Maigan A., Stewart Joshua M., Posgai Amanda L., Wasserfall Clive H., Atkinson Mark A., Brusko Todd M., Keselowsky Benjamin G., Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses, Frontiers in Immunology, 11, 2020. Crossref
-
Woittiez Nicky JC, Roep Bart O, Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray, Immunotherapy, 7, 2, 2015. Crossref
-
Sun Aixia, Hayat Hasaan, Sanchez Simon W., Moore Anna, Wang Ping, Magnetic Particle Imaging of Transplanted Human Islets Using a Machine Learning Algorithm, in Type-1 Diabetes, 2592, 2023. Crossref